MYC and myeloid leukemia: Our study showed that ribosome biogenesis is a key downstream of c-Myc, and matrine killed myeloid leukemia cell lines by inhibiting c-Myc-mediated ribosome biogenesis, suggesting that matrine is also a ribosome biogenesis inhibitor.